We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

In trading on Tuesday, shares of Denali Therapeutics Inc (Symbol: DNLI) crossed above their 200 day moving average of $23.11, changing hands as high as $23.33 per share. Denali Therapeutics Inc ...

William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...

Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained 26.6% against the industry’s decline of 14.3%. The stock has also ...

A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have lost about 21.2% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Fintel reports that on December 16, 2024, Stifel upgraded their outlook for Denali Therapeutics (NasdaqGS:DNLI) from Hold to Buy. As of December 3, 2024, the average one-year price target for ...

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) was the recipient of a significant growth in short interest in the month of December.As of December 31st, there was short interest ...

Fintel reports that on January 3, 2025, William Blair initiated coverage of Denali Therapeutics (NasdaqGS:DNLI) with a Outperform recommendation. As of December 23, 2024, the average one-year ...

Denali Therapeutics (NASDAQ:DNLI) on Monday said cash, cash equivalents, and marketable securities were approximately $1.28 billion as of September 30, 2024. Denali anticipates its cash runway will ...

Stock futures were mixed in Tuesday’s premarket session as investors looked ahead to the release of the Job Openings and Labor Turnover Survey (JOLTS) later in the day. Here are some of Tuesday's ...

The firm increased its portfolio allocation in DNLI by 16.85% over the last quarter. Wellington Management Group Llp holds 10,727K shares representing 7.45% ownership of the company. In its prior ...